ophtha lec aids&theye

Upload: james-abraham-dacanay-malala

Post on 08-Apr-2018

220 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/7/2019 OPHTHA lec aids&theye

    1/101

    Ocular Manifestations in HIV

    Infections

    Clinically apparent ocular lesions seen in

    94% of AIDS patients

    Four categories of involvement

    Neoplasms (kaposis sarcoma)

    Lesions related to microvascular disease

    Opportunistic ocular infections

    Neuro-ophthalmic abnormalities

  • 8/7/2019 OPHTHA lec aids&theye

    2/101

  • 8/7/2019 OPHTHA lec aids&theye

    3/101

  • 8/7/2019 OPHTHA lec aids&theye

    4/101

  • 8/7/2019 OPHTHA lec aids&theye

    5/101

  • 8/7/2019 OPHTHA lec aids&theye

    6/101

    Kaposi sarcoma

    AdvancedEarly

    Pink, red-violet lesion

    Vascular tumour occurring in patients with AIDS

    Usually associated with advanced disease

    Very sensitive to radiotherapy

    May ulcerate and bleed

  • 8/7/2019 OPHTHA lec aids&theye

    7/101

    Kaposis sarcoma

    May be overlooked unless lower lids are

    pulled down during exam

    Ocular surface or eyelid usually first site fordevelopment of this multifocal neoplasm in

    4% cases

    Ocular lesion may be the initial or only lesion

  • 8/7/2019 OPHTHA lec aids&theye

    8/101

  • 8/7/2019 OPHTHA lec aids&theye

    9/101

  • 8/7/2019 OPHTHA lec aids&theye

    10/101

    Conjunctiva Dilated vessels at the limbus

    Isolated vascular segments of irregular caliber

    Sludging of blood flow

  • 8/7/2019 OPHTHA lec aids&theye

    11/101

  • 8/7/2019 OPHTHA lec aids&theye

    12/101

  • 8/7/2019 OPHTHA lec aids&theye

    13/101

  • 8/7/2019 OPHTHA lec aids&theye

    14/101

  • 8/7/2019 OPHTHA lec aids&theye

    15/101

    Cotton wool spots Most common retinal manifestation (at

    least 2/3 of AIDS cases)

    Nerve fiber layer swelling

    Stasis of axoplasmic flow

    Reflection of retinal ischemia

    Spontaneously regresses in 4-6 weeks

  • 8/7/2019 OPHTHA lec aids&theye

    16/101

  • 8/7/2019 OPHTHA lec aids&theye

    17/101

  • 8/7/2019 OPHTHA lec aids&theye

    18/101

  • 8/7/2019 OPHTHA lec aids&theye

    19/101

  • 8/7/2019 OPHTHA lec aids&theye

    20/101

  • 8/7/2019 OPHTHA lec aids&theye

    21/101

  • 8/7/2019 OPHTHA lec aids&theye

    22/101

  • 8/7/2019 OPHTHA lec aids&theye

    23/101

  • 8/7/2019 OPHTHA lec aids&theye

    24/101

    Cytomegalovirus retinitis Early CMV difficult to distinguish from cotton

    wool spots

    No spontaneous resolution

    Relentlessly progressive

    Individual foci coalesce and spread outwards

    Necrotic retina replaced by thin, glioticmembrane -> retinal detachment

    NEED FOR SERIAL EXAMINATION

  • 8/7/2019 OPHTHA lec aids&theye

    25/101

  • 8/7/2019 OPHTHA lec aids&theye

    26/101

  • 8/7/2019 OPHTHA lec aids&theye

    27/101

  • 8/7/2019 OPHTHA lec aids&theye

    28/101

  • 8/7/2019 OPHTHA lec aids&theye

    29/101

  • 8/7/2019 OPHTHA lec aids&theye

    30/101

  • 8/7/2019 OPHTHA lec aids&theye

    31/101

  • 8/7/2019 OPHTHA lec aids&theye

    32/101

  • 8/7/2019 OPHTHA lec aids&theye

    33/101

  • 8/7/2019 OPHTHA lec aids&theye

    34/101

  • 8/7/2019 OPHTHA lec aids&theye

    35/101

    Cytomegalovirus retinitis Most common ocular infection (25%)

    Full thickness retinal necrosis

    Dry, granular, retinal opacification(edema / necrosis)

    Hemmorhage and vasculitis

  • 8/7/2019 OPHTHA lec aids&theye

    36/101

  • 8/7/2019 OPHTHA lec aids&theye

    37/101

  • 8/7/2019 OPHTHA lec aids&theye

    38/101

  • 8/7/2019 OPHTHA lec aids&theye

    39/101

  • 8/7/2019 OPHTHA lec aids&theye

    40/101

  • 8/7/2019 OPHTHA lec aids&theye

    41/101

  • 8/7/2019 OPHTHA lec aids&theye

    42/101

  • 8/7/2019 OPHTHA lec aids&theye

    43/101

  • 8/7/2019 OPHTHA lec aids&theye

    44/101

  • 8/7/2019 OPHTHA lec aids&theye

    45/101

    Cytomegalovirus retinitis Hematogenous spread

    Microvasculopathy ->damage vesselwall ->allow access of viral particles to

    retinal tissue

    Cotton-wool spots precede or occur

    concurrently

  • 8/7/2019 OPHTHA lec aids&theye

    46/101

    Cytomegalovirus retinitis Early lesions adjacent to major vascular

    arcades (vascular orientation)

    May also occur first in the peripheralretina

    Little inflammatory reaction; vitreous

    remains clear

  • 8/7/2019 OPHTHA lec aids&theye

    47/101

  • 8/7/2019 OPHTHA lec aids&theye

    48/101

  • 8/7/2019 OPHTHA lec aids&theye

    49/101

  • 8/7/2019 OPHTHA lec aids&theye

    50/101

  • 8/7/2019 OPHTHA lec aids&theye

    51/101

  • 8/7/2019 OPHTHA lec aids&theye

    52/101

  • 8/7/2019 OPHTHA lec aids&theye

    53/101

  • 8/7/2019 OPHTHA lec aids&theye

    54/101

    Cytomegalovirus retinitis

    Treatment

    Ganciclovir (IV or intravitreal at 200

    ug/0.1cc); watch out for neutropenia Foscarnet (IV); watch out for kidney damage

    (need proper hydration)

    AZT (azidothymidine) effective against HIV

    but no effect on CMV

    Laser - failure to prevent spread of CMV

    retinitis

  • 8/7/2019 OPHTHA lec aids&theye

    55/101

  • 8/7/2019 OPHTHA lec aids&theye

    56/101

  • 8/7/2019 OPHTHA lec aids&theye

    57/101

  • 8/7/2019 OPHTHA lec aids&theye

    58/101

  • 8/7/2019 OPHTHA lec aids&theye

    59/101

  • 8/7/2019 OPHTHA lec aids&theye

    60/101

  • 8/7/2019 OPHTHA lec aids&theye

    61/101

  • 8/7/2019 OPHTHA lec aids&theye

    62/101

  • 8/7/2019 OPHTHA lec aids&theye

    63/101

  • 8/7/2019 OPHTHA lec aids&theye

    64/101

  • 8/7/2019 OPHTHA lec aids&theye

    65/101

  • 8/7/2019 OPHTHA lec aids&theye

    66/101

  • 8/7/2019 OPHTHA lec aids&theye

    67/101

    CONGENITAL

    CATARACT

    most are bilateral

    associated with maternal infection

    Rubella, Toxoplasmosis,

    Cytomegalic Inclusion Disease

    may cause nystagmus

  • 8/7/2019 OPHTHA lec aids&theye

    68/101

  • 8/7/2019 OPHTHA lec aids&theye

    69/101

  • 8/7/2019 OPHTHA lec aids&theye

    70/101

  • 8/7/2019 OPHTHA lec aids&theye

    71/101

  • 8/7/2019 OPHTHA lec aids&theye

    72/101

  • 8/7/2019 OPHTHA lec aids&theye

    73/101

  • 8/7/2019 OPHTHA lec aids&theye

    74/101

  • 8/7/2019 OPHTHA lec aids&theye

    75/101

  • 8/7/2019 OPHTHA lec aids&theye

    76/101

  • 8/7/2019 OPHTHA lec aids&theye

    77/101

  • 8/7/2019 OPHTHA lec aids&theye

    78/101

  • 8/7/2019 OPHTHA lec aids&theye

    79/101

  • 8/7/2019 OPHTHA lec aids&theye

    80/101

  • 8/7/2019 OPHTHA lec aids&theye

    81/101

  • 8/7/2019 OPHTHA lec aids&theye

    82/101

  • 8/7/2019 OPHTHA lec aids&theye

    83/101

    Lagophthalmos

    Insufficient or weak

    eyelid closure

    May result toexposure keratitis

    Treatment: eyelid

    taping when

    sleeping; artificialtears

  • 8/7/2019 OPHTHA lec aids&theye

    84/101

    Fungal Keratitis

    Rare, but not in P.I.

    Farmers

    Causative agents: Aspergillus

    Fusarium

    Candida

  • 8/7/2019 OPHTHA lec aids&theye

    85/101

    Fungal Keratitis Signs and Symptoms:

    Redness, pain, profuse

    mucoid discharge ,

    intense anterior chamber

    reaction(non specific) Slow progression

    feathery borders

    Satellite lesions

    Endothelial plaque

  • 8/7/2019 OPHTHA lec aids&theye

    86/101

    Fungal Keratitis

    Treatment:

    Difficult

    Drops: Natamycin 5%

    Amphotericin B 0.15% eye drops

    IV/ Systemic antifungal drugs

    If large and with impending perforation

  • 8/7/2019 OPHTHA lec aids&theye

    87/101

    Fungal Keratitis

    Surgery

    Therapeutic

    transplant

    Perforated ulcers

  • 8/7/2019 OPHTHA lec aids&theye

    88/101

    Acanthamoeba

    Protozoa

    Contact lens wearers Differentiate from

    Pseudomonas (fastprogression, cornealmelt, profuse discharge)

    PAIN Radial keratoneurtitis

    Disproportionate toclinical signs

    Infiltrates Start out as satellite

    lesions

    Coalesce to form acentral ulceration

    ring inflitrates

  • 8/7/2019 OPHTHA lec aids&theye

    89/101

    Acanthamoeba

    Slow progression

    Epithelium may be intact

    CLUES:Severe pain

    Cultures negative for bacterial or fungal

    growth

    No response to typical antimicrobial or

    antifungal therapy

  • 8/7/2019 OPHTHA lec aids&theye

    90/101

    Acanthamoeba

    Treatment: Antiamoebic drugs

    Propamidine isothionate

    Polyhexamethylene biguanide chlorhexidine

    Steroids

    controversial

    May decrease pain but case delayed healing

    NSAIDS: better alternative

    Surgery Therapeutic transplants

    CONTRAINDICATED in inflamed eyes

  • 8/7/2019 OPHTHA lec aids&theye

    91/101

  • 8/7/2019 OPHTHA lec aids&theye

    92/101

    Sample Question

    Which therapy is least appropriate for treatment of

    dendritic epithelial keratitis due to herpes simplex

    virus?

    a. Vidarabine ointment 4 times a day

    b. Trifluoridine solution 4 times a day

    c. Oral acyclovir 2 grams a day

    d. Prednisolone acetate 1% qide. Minimal debridement with a dry cotton-tipped applicator

  • 8/7/2019 OPHTHA lec aids&theye

    93/101

    Viral Keratitis

    Herpes Simplex

    DNA virus

    Common: up to 90% of human population seropositive

    HSV1(face, lips, eyes)

    Primary infection

    In children, usually droplet

    subclinical

    Recurrence

    Immunocompromised state

  • 8/7/2019 OPHTHA lec aids&theye

    94/101

    Viral Keratitis

    Herpes Simplex

    Keratitis

    Two types Epithelial (HSEK)

    Disciform

    keratitis

  • 8/7/2019 OPHTHA lec aids&theye

    95/101

    Viral Keratitis

    HSEK Reduced corneal

    sensation

    Epithelial ulceration Anterior stromal infiltrates

    Dendrites

    Terminal bulbs

    Centrifugal spread toform geographic lesions

  • 8/7/2019 OPHTHA lec aids&theye

    96/101

    Viral Keratitis

    Disciform Keratitis

    Reduced corneal

    sensation

    Epithelial edema

    overlying stromal

    infiltrates

    DM folds

    Anterior uveitis

    IOP may be elevated

  • 8/7/2019 OPHTHA lec aids&theye

    97/101

    Viral Keratitis

    HSEK Treatment:

    Topical Antivirals

    Ganciclovir 0.15%

    Trifluorothymidine 1%

    Toxic

    Debridment

    Systemic Drugs

    Effect disappearswhen drug is removed

    For those with 2 ormore attacks/year

    Disciform Keratitis Treatment:

    Topical Antivirals

    Steroids

    Given withantivirals

    Tapering dose

    Small lesions may beobserved

  • 8/7/2019 OPHTHA lec aids&theye

    98/101

  • 8/7/2019 OPHTHA lec aids&theye

    99/101

    Viral Keratitis

    Herpes Zoster Ophthalmicus(HZO)

    Caused by varicella (VZV)

    Face lesions (Vesicles)

    follow nerve distribution,respects midline

    HutchinsonsSign

    Keratitis:

    Epithelial

    Dendrites with nobulbs

    NummularSubepithelialopacities

    Disciform keratitis

    Similar to Herpessimplex

  • 8/7/2019 OPHTHA lec aids&theye

    100/101

    Viral Keratitis

    Herpes Zoster Ophthalmicus:

    Other findings

    Blepharoconjunctivitis Associated with lid vesicles

    Episcleritis

    Scleritis

    Anterior uveitis Sectoral iris atrophy

  • 8/7/2019 OPHTHA lec aids&theye

    101/101